Insulin antibody syndrome results in insulin resistance, hyperglycemia and later hypoglycemia.

Therapies for insulin antibody syndrome are anecdotal and include plasmapheresis, immunosuppression and glucocorticoids.

The most common current recommendation is combined intravenous and oral immunosuppressants.

In this case we show the efficacy of the more convenient and economic oral immunosuppressant monotherapy.